Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $188.33 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.